Afleveringen
-
Join Drs. Mike Wilkes and Mark Ebell as they discuss digital behavioral therapy to treat symptoms of fibromyalgia:
Gendreau RM, McCracken LM, Williams DA, et al. Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): A phase 3, multicentre, randomised controlled trial. Lancet 2024;404(10450):364-374.
-
Join Drs. Mike Wilkes and Mark Ebell as they discuss a new randomized trial of probiotics for UTI:
Gupta V, Mastromarino P, Garg R. Effectiveness of prophylactic oral and/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2024;78(5):1154-1161.
-
Zijn er afleveringen die ontbreken?
-
This week, Drs Wilkes and Ebell discuss a new meta-analysis of the CV benefit of SGLT-2 inhibitors, which is less dramatic than you might think.
-
This week primary care Drs. Wilkes and Ebell talk about the long term harms of multiple UTIs in children.
-
This week Mike and Mark discuss a new meta-analysis summarizing all of the data on the benefits of antibiotics for kids.
-
Join primary care physicians Drs. Mike Wilkes and Mark Ebell as they discuss the comparative death rates for patients hospitalized with influenza, RSV and COVID-19
